Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China

This study has been completed.
Sponsor:
Collaborators:
National Institute of Mental Health (NIMH)
National Center for AIDS/STD Control and Prevention, China CDC
Beijing YouAn Hospital
Beijing Ditan Hospital
Peking University
Information provided by (Responsible Party):
Scott Letendre, University of California, San Diego
ClinicalTrials.gov Identifier:
NCT01340950
First received: April 21, 2011
Last updated: March 31, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2015
  Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)